Shih‐Li Su

937 total citations
37 papers, 755 citations indexed

About

Shih‐Li Su is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Shih‐Li Su has authored 37 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in Shih‐Li Su's work include Diabetes Treatment and Management (10 papers), Diabetes Management and Research (9 papers) and Signaling Pathways in Disease (5 papers). Shih‐Li Su is often cited by papers focused on Diabetes Treatment and Management (10 papers), Diabetes Management and Research (9 papers) and Signaling Pathways in Disease (5 papers). Shih‐Li Su collaborates with scholars based in Taiwan and China. Shih‐Li Su's co-authors include Shih‐Te Tu, Ming‐Chia Hsieh, Shi-Dou Lin, I‐Te Lee, Wayne Huey‐Herng Sheu, Chin‐San Liu, Jun‐Sing Wang, Shuyi Wang, Shih‐Yi Lin and Chi‐Chen Lin and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Shih‐Li Su

37 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shih‐Li Su Taiwan 16 377 253 127 107 81 37 755
Caroline Pereira Domingueti Brazil 11 188 0.5× 204 0.8× 106 0.8× 102 1.0× 86 1.1× 33 805
Jin Shang China 20 480 1.3× 128 0.5× 116 0.9× 83 0.8× 115 1.4× 56 999
Sahar K. Hegazy Egypt 13 314 0.8× 109 0.4× 66 0.5× 88 0.8× 65 0.8× 36 695
Ingrid Kazue Mizuno Watanabe Brazil 12 308 0.8× 91 0.4× 150 1.2× 59 0.6× 66 0.8× 23 729
Qing Su China 17 421 1.1× 188 0.7× 180 1.4× 129 1.2× 199 2.5× 46 1.1k
Michihiro Hosojima Japan 16 231 0.6× 129 0.5× 115 0.9× 92 0.9× 63 0.8× 50 843
Xiaofa Qin United States 19 405 1.1× 212 0.8× 142 1.1× 286 2.7× 160 2.0× 36 1.1k
Yi Ching Chen Taiwan 13 201 0.5× 177 0.7× 60 0.5× 93 0.9× 95 1.2× 29 698
Mevlüt Başkol Türkiye 17 263 0.7× 180 0.7× 99 0.8× 143 1.3× 291 3.6× 50 1.0k
Heng Miao China 14 371 1.0× 108 0.4× 126 1.0× 63 0.6× 203 2.5× 37 809

Countries citing papers authored by Shih‐Li Su

Since Specialization
Citations

This map shows the geographic impact of Shih‐Li Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shih‐Li Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shih‐Li Su more than expected).

Fields of papers citing papers by Shih‐Li Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shih‐Li Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shih‐Li Su. The network helps show where Shih‐Li Su may publish in the future.

Co-authorship network of co-authors of Shih‐Li Su

This figure shows the co-authorship network connecting the top 25 collaborators of Shih‐Li Su. A scholar is included among the top collaborators of Shih‐Li Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shih‐Li Su. Shih‐Li Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Tsung‐Hui, Chun-Ju Chang, Wei‐Wen Su, et al.. (2023). Using the Diabetes Care System for a County-Wide Hepatitis C Elimination: An Integrated Community-Based Shared Care Model in Taiwan. The American Journal of Gastroenterology. 119(5). 883–892. 2 indexed citations
2.
Wu, Shey‐Lin, Ko‐Hung Liu, Wen‐Ling Cheng, et al.. (2020). Growth hormone rescue cerebellar degeneration in SCA3 transgenic mice. Biochemical and Biophysical Research Communications. 529(2). 467–473. 3 indexed citations
3.
Kuo, Chen‐Ling, et al.. (2019). A Novel Biomarker CD147 Predict Mortality in Diabetes Patients After a 10-Year Follow-Up. 17(1). 1–7. 3 indexed citations
4.
Lin, Ching‐Hsiung, Shu‐Chen Kuo, Ming‐Chia Hsieh, et al.. (2019). Effect of diabetes mellitus on risk of latent TB infection in a high TB incidence area: a community-based study in Taiwan. BMJ Open. 9(10). e029948–e029948. 21 indexed citations
5.
Hsieh, Ming‐Chia, Wan-Hua Tsai, Shih‐Li Su, et al.. (2018). The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial. Scientific Reports. 8(1). 16791–16791. 138 indexed citations
8.
Chen, Yahui, Wei‐Wen Lin, Chin‐San Liu, et al.. (2016). Caveolin-1 Expression Ameliorates Nephrotic Damage in a Rabbit Model of Cholesterol-Induced Hypercholesterolemia. PLoS ONE. 11(4). e0154210–e0154210. 9 indexed citations
9.
Chen, Yahui, Wei‐Wen Lin, Chin‐San Liu, et al.. (2014). Caveolin-1 Provides Palliation for Adverse Hepatic Reactions in Hypercholesterolemic Rabbits. PLoS ONE. 9(1). e71862–e71862. 13 indexed citations
10.
Tsai, Yi‐Ting, Jun‐Sing Wang, Shi-Dou Lin, et al.. (2014). Post-meal β-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin monotherapy after addition of glibenclamide or acarbose. Diabetology & Metabolic Syndrome. 6(1). 68–68. 12 indexed citations
11.
Su, Shih‐Li, et al.. (2013). Fibroblast Growth Factor 21 Predicts Type 2 Diabetes in Taiwanese. 11(1). 42–47. 3 indexed citations
12.
Su, Shih‐Li, Wenfu Wang, Shey‐Lin Wu, et al.. (2012). FGF21 in ataxia patients with spinocerebellar atrophy and mitochondrial disease. Clinica Chimica Acta. 414. 225–227. 13 indexed citations
13.
Chen, Yahui, Chi‐Wei Yeh, Hui‐Chen Lo, et al.. (2012). Generation of reactive oxygen species mediates butein-induced apoptosis in neuroblastoma cells. Oncology Reports. 27(4). 1233–1237. 43 indexed citations
14.
Kuo, Chen‐Ling, et al.. (2012). Endogenous granulocyte colony-stimulating factor: a biomarker in acute ischemic stroke. Biomarkers. 17(4). 319–324. 10 indexed citations
16.
Huang, Ching-Hui, Shih‐Li Su, Ming‐Chia Hsieh, et al.. (2011). Depleted Leukocyte Mitochondrial DNA Copy Number in Metabolic Syndrome. Journal of Atherosclerosis and Thrombosis. 18(10). 867–873. 45 indexed citations
17.
Wang, Jun‐Sing, Shih‐Te Tu, I‐Te Lee, et al.. (2010). Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring. Diabetes/Metabolism Research and Reviews. 27(1). 79–84. 87 indexed citations
18.
Liu, Chin‐San, Chong‐Kuei Lii, Li‐Ling Chang, et al.. (2010). Atorvastatin increases blood ratios of vitamin E/low-density lipoprotein cholesterol and coenzyme Q10/low-density lipoprotein cholesterol in hypercholesterolemic patients. Nutrition Research. 30(2). 118–124. 17 indexed citations
19.
Hwang, Jawl‐Shan, Di Wu, Keh‐Sung Tsai, et al.. (2008). The Effects of Strontium Ranelate in Asian Women with Postmenopausal Osteoporosis. Calcified Tissue International. 83(5). 308–314. 16 indexed citations
20.
Wang, Shuyi, et al.. (2005). Sheehan's Syndrome Presenting with Early Postpartum Congestive Heart Failure. Journal of the Chinese Medical Association. 68(8). 386–391. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026